AGP Executive Report

Chronic Pain & CBD: An Australian-made CBD tablet trial (155 people) was safe but didn’t beat placebo for chronic pain, though a small share reported some relief—still, it’s fueling interest in THC-free cannabis options. Pediatric Safety: Canadian doctors warn accidental cannabis poisonings are rising, especially from edible products that look like regular candy, with delayed sleepiness and sedation as key red flags. Cannabis Policy Fight: Massachusetts’ big Freedom Rally drew thousands ahead of a Nov. 3 ballot vote that would repeal recreational marijuana legalization—campaigners are urging voters to say “No.” Enforcement & Seizures: Hong Kong Customs arrested a passenger after finding about 5kg of suspected cannabis buds in luggage; in Azerbaijan transit, authorities seized marijuana hidden in celery shipments. Public Health & Risk: A separate report highlights increasing kratom/7-OH withdrawal cases at addiction clinics, as regulators move to curb 7-OH products. Community Health: A New Jersey loneliness analysis (from Mood.com) found Passaic County highest in reported loneliness, with broader social disconnection rates near the national average.

CBD & Cannabis Enforcement: Nigeria’s NDLEA says it seized 1.3M tramadol pills and 6,000kg of cannabis worth over N3.4bn, including a “fake police officer” bust. Drug-Related Police Action: In Zimbabwe, police arrested a suspected dealer after a CBD chase ended in a crash; officers recovered dagga and “Gorilla Glue” plus pain syrups. Medical Cannabis Access: Kentucky held a Cannabis and Wellness Expo to educate patients on the state’s newer medical marijuana program. International Cannabis Case: A Singapore permanent resident was jailed 27 months for ordering cannabis via Telegram from Britain; SingPost intercepted a parcel with 136g. Cannabis in Daily Life: A UK carer was banned from driving after admitting he used cannabis to sleep, with THC and cocaine metabolites found. Research & Health: A review highlights India’s Leucas aspera as a potential medicinal plant, while another study explores how plant extracts can boost or block rice germination.

Public Health Alert (Nigeria): NAFDAC confirmed 48 deaths and 182 illnesses tied to suspected toxic herbal/alcohol drinks in Ondo State, with reports of methanol and cannabis indica found in samples; victims faced symptoms including visual problems and rapid deterioration, and officials say figures are still being verified. Drug Enforcement (Nigeria): NDLEA seized 1.3 million tramadol pills and about 6,000kg of cannabis worth N3.4 billion, also arresting a suspect who allegedly posed as a police officer while transporting drugs. Medical Cannabis & Safety (UK): A carer in Hereford was banned from driving for 18 months after testing showed cocaine metabolites and THC; he said he used cannabis to sleep. CBD/Cannabis Policy (EU): An EU watchdog recommended the first food approval for CBD, a potential milestone for how CBD edibles are regulated. Cannabis in the News (US): A report says Pat McAfee was trolled after appearing to smoke weed or CBD on ESPN. Health & Wellness (Diet): A cardiologist says you may not need fish to get omega-3s, pointing to plant sources and possible algae-based supplements.

Public Health Crisis: Nigeria’s NAFDAC confirmed 48 deaths and 182 illnesses tied to methanol-laced locally prepared alcoholic/herbal drinks in Ondo State, with victims reporting severe symptoms including visual problems; lab tests also found cannabis indica in samples, and authorities say some people were totally or partially blinded. CBD & Cannabis in the News: A Toronto man was acquitted in a cannabis-induced choking attack case after a judge accepted a defense tied to cannabis effects; meanwhile, a pop-up “Electric Lettuce” event is marketing THC-infused fine-dining as a way to normalize edibles beyond “just a brownie.” Medical/Wellness Angle: A cardiologist says you don’t have to eat fish to get omega-3s, pointing to plant sources and algae-based supplements as options. Policy/Access: Colorado’s student discipline fight continues, with attorneys arguing schools can’t punish off-campus social media posts without violating the First Amendment. Local Lifestyle Shift: Tempe bars and restaurants are adapting as fewer people drink, with marijuana cited as one alternative.

Toxicology Update (Ondo, Nigeria): NAFDAC says methanol-contaminated locally made alcoholic and herbal drinks linked to Ondo State deaths have killed 48 people and sickened 182, with 5 totally blind and 2 partially blind; lab tests also found Cannabis indica in some samples, and authorities report 15 arrests tied to production and sale. Medical Cannabis Safety (Maine, US): Maine warns patients about “Deep Sea” cannabis concentrate sold by Ganja World after testing found unsafe butane levels; the product was removed and patients are urged to seek care if symptoms show up. Cannabis in Court (Canada): A Toronto man accused of choking a 7-year-old after vaping cannabis was acquitted, with the judge citing nonmental disorder automatism. CBD/Canna Culture: A Cincinnati pop-up “Electric Lettuce” is marketing THC-infused fine-dining as a way to reframe edibles beyond brownies. Workplace/Policy Watch: Quest Diagnostics reports rising positive marijuana and cocaine results in workplace drug tests, with hair tests showing the biggest marijuana jump.

CBD in EU food: The European Food Safety Authority gave its first positive opinion for CBD in food, clearing a CBD oil-based supplement as safe up to 2 mg/day for adults (not pregnant or lactating), paving the way for EU approval under Novel Foods rules. Medical cannabis safety alert: Maine health officials warned patients about contaminated “Deep Sea” cannabis concentrate sold by Ganja World after testing found unsafe butane levels; the product was removed and patients with symptoms were told to contact a clinician. Clinical cannabis outcomes: A 10-year study in chronic low back pain reported medical cannabis was linked to major opioid reductions (about 90%), plus lower pain and disability. Research pipeline: News also highlighted CBD’s potential in ischemic stroke therapy via NRF2 antioxidant activity and angiogenesis pathways, plus a new UMBRAA blinding framework aimed at improving psilocybin trial masking. Access & retail: Illinois’ Terrabis won approval to serve medical cannabis patients at its Grayville dispensary alongside adult-use. Hemp market pressure: American hemp sellers are bracing for a looming ban on most products, calling it devastating.

Medical Cannabis Driving Reform (NSW): NSW passed major changes letting eligible medicinal cannabis patients drive with THC below a set threshold, with registration, a safety program, and a “three-strike” approach for roadside positives. Alabama Access Update: BamaBloom opened a new dispensary in Athens, marking the third in-state location as Alabama works through licensing delays after years of litigation; patients can buy oils, topicals, capsules and gel caps (no flower). Research & Products: A study highlights cancer patients reporting symptom relief and sustained improvements after medical cannabis, while another report links cannabis products to improvements in inflammatory arthritis. Hemp Tech: Korean researchers strengthened biodegradable plastics using hemp hurd, aiming to improve packaging and mulch film performance. Local Policy Watch: Castle Rock advanced an ordinance to prohibit retail kratom sales, as residents push back. Public Health Pressure (Guam): Guam reported elevated suicide deaths in 2024, with local leaders calling for stronger mental health and substance-use support. Campus Risk Debate: A piece warns students may be underestimating marijuana dangers, pointing to normalization on campuses.

Medical Cannabis Research: A UK registry study reports sustained improvements in pain, sleep, and quality of life for people with inflammatory arthritis using medical cannabis preparations, with mostly mild side effects. Surgery & Cannabis/GLP-1: New HSS research flags that common pre-op stomach-emptying checks may not clearly predict aspiration risk as GLP-1 use and cannabis become more common. Patient-Reported Cannabis Use: An Australian survey finds many people with eating disorders use cannabis, often daily, and rate it as more helpful than prescription options—fueling calls for better clinical trials. Arthritis & Cannabis Products: A new observational study adds to the growing medical-cannabis outcomes picture for inflammatory arthritis. Local Access: Alabama’s third dispensary in the state opened in Athens (BamaBloom), with more locations expected soon. CBD/Minor Cannabinoids: A Reddit-based analysis suggests patients keep mentioning lesser-known cannabinoids like CBG/CBN as helpful, even if it can’t replace clinical trials. Policy/Industry: Ecuador’s hemp sector is expanding fast into finished goods like gummies, cosmetics, and pet products.

Hemp Regulation Shock: A Dec. 11 federal ban on most hemp-derived THC products is already forcing U.S. sellers to scramble, with one Illinois retailer saying the compliant slice of sales is under 10% and the rest is about to get shut down. Medical Cannabis Research: A new large study reports cancer patients seeing symptom relief with medicinal marijuana, adding to growing support for CBD/cannabis in pain and nausea care. Psychedelics Push (Veterans): The American Legion is urging Congress to create a VA office to expand research and delivery of psychedelic therapies for treatment-resistant PTSD, anxiety, and depression. Mental Health + First Response: NAMI honored Ohio deputies for crisis intervention training, highlighting how better response can reduce harm during mental health emergencies. Policy Watch: Congress’s year-end health care “extenders” could reshape Medicare payments, insulin costs, and PBM reform—key issues for patients using CBD and other wellness products. Cannabis Access Tightening: Multiple reports this week point to tightening rules and enforcement uncertainty around THC hemp products, leaving retailers in limbo.

Youth Overdose Warning: A CDC review found cannabis shows up in 42.7% of overdose deaths among teens (12–17), with fentanyl involved in nearly 9 of 10 cannabis-positive cases—raising alarms that cannabis may be a marker for broader polydrug risk. Hemp THC Crackdown: Wisconsin’s Hemp 1848 is back open after raids and THC-related charges against owner Jerry McCoy, with staff saying they’re selling licensed hemp THCA products while rebuilding inventory. Illegal Market & Violence Claims: A Siskiyou County sheriff warned of a Chinese-linked illegal cannabis network tied to violence and water theft, estimating some grows could be worth $2B+ annually (not independently verified). Medical Cannabis & Pain: A study roundup highlights cancer patients reporting symptom relief with medical cannabis, including pain and nausea. Policy & Access: Texas’ THC ban is set to push some hemp-derived THC products into Schedule 1 status, potentially increasing penalties and stigmatizing regulated access. Research Methods: UCSF-led researchers argue psychedelic trials need more convincing placebos to protect masking, since participants can often tell when they’ve received the real drug.

Cannabis & Sleep: A new column digs into whether cannabis helps or hurts sleep, citing people who stop using and report more vivid dreams and better rest, while also weighing what doctors say about the science. Medical Cannabis Access Tightening: Australian regulators are sharpening scrutiny on how cannabis medicines reach patients, with guidance changing expectations for prescribing and dispensing even without changing the underlying law. CBD Trial Milestone: Avecho’s pivotal insomnia study for a cannabidiol capsule cleared an independent monitoring board to keep recruiting, with Australian rights already licensed to a global generics partner. Company Watch (CBD/Obesity): Artelo Biosciences says its oral ART27.13 (a dual cannabinoid receptor agonist) matched semaglutide weight loss in obese mice and doubled it in combination in a nonclinical obesity model. Regulatory/Quality Focus: Neurotech International is pursuing a registration-focused route for a cannabinoid candidate in paediatric neurology, aiming to build trial evidence rather than rely on exemption pathways. Enforcement & Safety: Nebraska troopers seized nearly 20,000 pounds of drugs worth $50M in a major I-80 stop, including marijuana, THC products, and psilocybin.

CBD & Seizures Research: A new synthetic CBD derivative reduced seizure severity in mice and avoided sedation, pointing to next-gen options for developmental epilepsy syndromes. Medical Cannabis for Pain: A long-term observational study reports back pain patients saw sustained improvements and cut opioid and other meds use after medical cannabis treatment. Cancer Symptom Relief: Multiple reports highlight medicinal cannabis benefits for cancer patients, including symptom improvement and reduced reliance on pharmaceuticals. Policy & Legal Markets: Minnesota says legal cannabis sales topped $250M in a year, with $45.6M in tax revenue and hundreds of new businesses; meanwhile, Texas hemp rules remain in flux as states push to ban intoxicating hemp products. Industry & Regulation: FDA cleared a first generic radioligand cancer drug, while Sionna Therapeutics announced major layoffs after a failed cystic fibrosis trial. Community & Safety: NYC unveiled a plan to reduce overcrowding in juvenile detention centers using more community-based supports.

Medical Cannabis Access & Policy: Alabama opened its third medical cannabis dispensary in Athens (BamaBloom), with more locations expected soon, while Texas still has major legal confusion over whether smokable hemp flower and concentrate can be possessed without felony risk. Industry & Community: New Jersey’s Shore House Canna is bringing back its 3rd Annual Fall Fest (Sept 26) with on-site consumption and local vendors. Research & Health: A new report flags rising weed pollen tied to El Niño and wet weather, and a separate study roundup points to medical cannabis symptom relief for cancer patients. Safety & Enforcement: A Seattle man was sentenced to 17 years for recruiting minors for violent robberies that included a dispensary worker’s death; meanwhile, Chennai customs seized 2.794 kg of hydroponic ganja at the airport. Business Watch: Avicanna’s CEO will present at a Sept 17 investor forum, and Australian small-cap cannabis names like Neurotech and Althea are drawing attention for execution-focused updates.

Big Bust: Nebraska State Patrol says it seized nearly 20,000 pounds of marijuana, THC products and mushrooms in a Sept. 4 I-80 stop near Cozad—calling it the agency’s biggest-ever haul, with an estimated street value over $50M. Medical Cannabis Research: Minnesota’s Office of Cannabis Management reports a large study of 6,621 cancer patients (2015–2023) showing symptom relief, including pain, nausea, vomiting, appetite and sleep improvements after medical cannabis use. Cancer Legal Fight: A Missouri judge is holding a “fairness” hearing over a proposed $7.25B Roundup settlement for cancer victims, with critics arguing payouts favor lawyers and Bayer’s glyphosate business. Industry/Policy Watch: Hemp-THC businesses brace for a November ban as Missouri’s intoxicating hemp rules tighten, with a federal ban timeline also shifting. Safety & Enforcement: Oregon police say a multi-agency raid on illegal weed farms rescued dozens of trafficking victims and destroyed more than 110,000 plants. Product News: Glass House Brands launched Mama Sue Professional Athlete Balm, a CBD-rich topical now selling in select California dispensaries. Legal/Market Risk: A federal appeals court ruling in Michigan says courts can’t enforce marijuana buy/sell contracts if the deal requires federal crimes. Public Health Warning: A San Francisco teen overdose case highlights a newly identified synthetic opioid, cychlorphine, after an autopsy found it instead of fentanyl.

Topical CBD in retail: Glass House Brands launched Mama Sue Professional Athlete Balm in California, pitching a high-potency cannabis topical with transdermal tech for “cooling pain relief,” now sold at select licensed dispensaries. Medical cannabis research: Corbus Pharmaceuticals reported positive topline Phase 1b CANYON-1 data for oral CRB-913 in obesity—5% mean weight loss at 60mg after 12 weeks—with a safety profile described as favorable vs marketed oral GLP-1s. Regulation & market pressure: Missouri’s medical marijuana industry faces “chaos” as hemp THC businesses brace for a ban this fall; meanwhile, Missouri hemp operators are preparing for a looming federal ban. Public health & harm reduction: B.C. updated overdose prevention guidance for post-secondary schools, aiming for consistent awareness and response protocols. Cannabis safety/usage disorder: A piece highlights cannabis use disorder risk (including lung cancer risk for heavy users) and points readers to help resources. Enforcement headlines: A UK man jailed after failing to attend court over a cannabis stash; separate reports describe drug seizures and ongoing anti-trafficking operations. Community product spotlight: Sleepy Hollow’s Quality High marked one year with sales focused on sleep gummies and other cannabis formats.

Medical Cannabis & Cancer Care: A Minnesota study of 6,621 cancer patients in the state program found symptom improvements after medical cannabis use, including vomiting, nausea, appetite loss, anxiety, depression and pain. CBD Topicals for Pain: A UK report spotlights a fragrance-free CBD balm (800mg CBD + CBG) marketed for muscle and joint relief, with claims of easing discomfort within 15–20 minutes. Misinformation Warning: Experts are urging people to avoid “medfluencers” and AI “doctors” pushing fake cancer tests, fertility “cures,” and other dangerous unproven treatments. Hemp Policy Watch: Missouri is moving ahead with restrictions on hemp THC products as a federal ban delay looms, with possible reassessment in 2027. Public Health & Safety: A separate piece notes THC gummies and vapes can be risky if dosage and timing aren’t handled carefully—effects can take much longer to hit with edibles. Caregiver Support: A nonprofit program launches to help parents respond to children’s mental health struggles early, citing screen time, anxiety, sleep issues and bullying as common warning signs.